480 related articles for article (PubMed ID: 31652837)
1. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.
Kaffe E; Magkrioti C; Aidinis V
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652837
[TBL] [Abstract][Full Text] [Related]
2. Implications of the lysophosphatidic acid signaling axis in liver cancer.
Lopane C; Agosti P; Gigante I; Sabbà C; Mazzocca A
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):277-282. PubMed ID: 28591560
[TBL] [Abstract][Full Text] [Related]
3. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin and chronic inflammatory diseases.
Magkrioti C; Galaris A; Kanellopoulou P; Stylianaki EA; Kaffe E; Aidinis V
J Autoimmun; 2019 Nov; 104():102327. PubMed ID: 31471142
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin in Pathophysiology and Pulmonary Fibrosis.
Ninou I; Magkrioti C; Aidinis V
Front Med (Lausanne); 2018; 5():180. PubMed ID: 29951481
[TBL] [Abstract][Full Text] [Related]
6. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease.
Flores-López M; García-Marchena N; Pavon FJ; Lara E; Porras-Perales O; Araos P; Requena-Ocaña N; Torres-Galván S; Mañas-Padilla MC; Rubio G; Suárez J; Santín LJ; Rodríguez de Fonseca F; Castilla-Ortega E; García-Fernández MI; Serrano A
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572393
[TBL] [Abstract][Full Text] [Related]
7. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
8. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
She S; Zhang Q; Shi J; Yang F; Dai K
Front Oncol; 2022; 12():922945. PubMed ID: 35769713
[TBL] [Abstract][Full Text] [Related]
9. Exosome-associated lysophosphatidic acid signaling contributes to cancer pain.
Khasabova IA; Khasabov SG; Johns M; Juliette J; Zheng A; Morgan H; Flippen A; Allen K; Golovko MY; Golovko SA; Zhang W; Marti J; Cain D; Seybold VS; Simone DA
Pain; 2023 Dec; 164(12):2684-2695. PubMed ID: 37278638
[TBL] [Abstract][Full Text] [Related]
10. The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer.
Erstad DJ; Tager AM; Hoshida Y; Fuchs BC
Mol Cell Oncol; 2017; 4(3):e1311827. PubMed ID: 28616586
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
[TBL] [Abstract][Full Text] [Related]
12. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
13. Autotaxin in liver fibrosis.
Ikeda H; Yatomi Y
Clin Chim Acta; 2012 Nov; 413(23-24):1817-21. PubMed ID: 22820036
[TBL] [Abstract][Full Text] [Related]
14. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
Baader M; Bretschneider T; Broermann A; Rippmann JF; Stierstorfer B; Kuttruff CA; Mark M
Br J Pharmacol; 2018 Feb; 175(4):693-707. PubMed ID: 29197066
[TBL] [Abstract][Full Text] [Related]
18. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome dynamics of the autotaxin-lysophosphatidic acid axis during muscle regeneration reveal proliferative effects in mesenchymal fibro-adipogenic progenitors.
Contreras O; Harvey RP
Front Cell Dev Biol; 2023; 11():1017660. PubMed ID: 36910157
[TBL] [Abstract][Full Text] [Related]
20. The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target?
Gallardo FS; Córdova-Casanova A; Brandan E
J Cell Commun Signal; 2021 Sep; 15(3):317-334. PubMed ID: 33689121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
